Literature DB >> 23933757

Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia.

I Sánchez-Ortega1, M Arnan1, B Patiño1, M J Herrero2, S Querol3, R F Duarte1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23933757     DOI： 10.1038/bmt.2013.113

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

1.  Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Ashley N Miller; Ashley Glode; Kathy R Hogan; Christine Schaub; Cindy Kramer; Robert K Stuart; Luciano J Costa
Journal:  Biol Blood Marrow Transplant       Date:  2010-12-23       Impact factor: 5.742

2.  Cord-blood transplantation in patients with leukemia--a real alternative for adults.

Authors:  Miguel A Sanz
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

Review 3.  Donor selection for unrelated cord blood transplants.

Authors:  Eliane Gluckman; Vanderson Rocha
Journal:  Curr Opin Immunol       Date:  2006-08-08       Impact factor: 7.486

4.  Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

Authors:  Hongtao Liu; Elizabeth S Rich; Lucy Godley; Olatoyosi Odenike; Loren Joseph; Susana Marino; Justin Kline; Vu Nguyen; John Cunningham; Richard A Larson; Paula del Cerro; Linda Schroeder; Lisa Pape; Wendy Stock; Amittha Wickrema; Andrew S Artz; Koen van Besien
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

5.  Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.

Authors:  Mi Kwon; Pascual Balsalobre; David Serrano; A Pérez Corral; Ismael Buño; Javier Anguita; Jorge Gayoso; Jose Luis Diez-Martin
Journal:  Biol Blood Marrow Transplant       Date:  2012-09-06       Impact factor: 5.742

6.  Defining the intensity of conditioning regimens: working definitions.

Authors:  Andrea Bacigalupo; Karen Ballen; Doug Rizzo; Sergio Giralt; Hillard Lazarus; Vincent Ho; Jane Apperley; Shimon Slavin; Marcelo Pasquini; Brenda M Sandmaier; John Barrett; Didier Blaise; Robert Lowski; Mary Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-01       Impact factor: 5.742

Review 7.  Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors.

Authors:  Manuel N Fernández
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

Review 8.  Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.

Authors:  Vanderson Rocha; Eliane Gluckman
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998
  8 in total
  2 in total

Review 1.  Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Authors:  A Sureda; P Bader; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; J C Marsh; A Nagler; C Peters; A Velardi; M Mohty; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

2.  Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.

Authors:  Hua Li; Xiaofan Li; Yiling Chen; Duihong Li; Xianling Chen; Zhijuan Zhu; Yiting Wang; Jiafu Huang; Ping Chen; Yuanzhong Chen; Nainong Li
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.